Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.OctoPlus has announced the expansion of drug delivery technology evaluation contract with a pharmaceutical company.
Subscribe to our email newsletter
As per the extended contract, the company will develop a controlled release formulation that combines the client’s optimized product candidate with their proprietary drug delivery technology, PolyActive.
If the project is successful, the contract may advance to a full process development and manufacturing contract, and a licensing agreement, the company said.
The studies conducted by OctoPlus for previous compounds of the client and pre-clinical studies performed with the prototype controlled release formulation were also successful.